News

Costco sees lift in June sales

BY Antoinette Alexander

ISSAQUAH, Wash. — Costco reported on Thursday a 10% boost in June sales as same-store sales climbed 6%.

Net sales for the month totaled $10.9 billion, an increase of 10% from $9.9 billion in the year-ago period. Both years' five-week periods included 34 selling days in Canada and the United States, reflecting the observance of Canada Day and Independence Day in the United States, respectively.

In the United States, same-store sales rose 6% and total company same-store sales also rose 6% during the month.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Ateb licenses Walgreens’ entire portfolio of prescription alignment patents

BY Michael Johnsen

RALEIGH, N.C. — Ateb on Thursday announced it has reached an agreement to license Walgreens' entire portfolio of prescription alignment patents in an effort to continue to improve overall health care, demonstrate the value of medication synchronization and increase patient adherence rates.
 
By securing this licensing, Ateb has insured that its customers may continue to use Ateb's Time My Meds solution. Time My Meds helps patients improve their overall health and gives pharmacists the opportunity to administer additional services, such as immunizations, comprehensive medication reviews and wellness programs. Ateb’s Adherence Solutions for pharmacy help increase medication adherence, generate prescription sales and improve patient loyalty, the company noted.
 
"The time to focus on the way pharmacy impacts how health care is delivered is now, and Ateb believes pharmacy is the best solution for affordable, effective health care," the company stated. "As trusted, accessible healthcare experts, pharmacists are perfectly positioned to advise patients on their medication therapy and guide patients to better healthcare outcomes."
 
Ateb reported more than 250,000 patients are already being managed in Time My Meds, and pharmacies using Time My Meds continue to deliver increased patient medication adherence rates and improved patient health.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

FDA issues warning letter to Zarbee’s for making treatment claims regarding its supplement products

BY Michael Johnsen

SILVER SPRING, Md. — The Food and Drug Administration in late June issued a warning letter to Zarbee's for making therapeutic claims regarding a dietary supplement product. "The therapeutic claims on your website establish that the products are drugs because they are intended for use in the cure, mitigation, treatment or prevention of disease," the agency wrote. "[I]ntroducing or delivering these products for introduction into interstate commerce for such uses violates the Act."
 
Examples of some of the treatment claims made by Zarbees include that its Zarbee’s Naturals Children’s Cough Syrup-Grape “calms coughs.”
 
The agency also found fault with Zarbee's customer testimonials on its site, and criticized the company for "liking" testimonials on its Facebook page. "Zarbees 'liked' the following comment made on Feb. 11, 2014," the agency wrote, regarding the company's children’s Sleep remedy. "[Customer:] 'I received the free sample … and … gave it to my daughter … I could not believe how well it worked! She was recently diagnosed with ADHD and put on medication … causing insomnia.'"
 
Zarbee's has until mid-July to respond to the FDA warning letter. "Failure to promptly correct these violations may result in legal action without further notice, including seizure and/or injunction," the agency warned. 
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES